← THE EVIDENCE INDEXThe Study Library.
8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
Showing studies that examined broccoli. Clear
People assigned to a diet, food or program and measured.
2 studies
2019 / Randomized, placebo-controlled, multidose trial
In Qidong, China, 170 subjects were randomized to consume a placebo drink (n = 55) or one of three doses of a broccoli sprout beverage—full (n = 25), one-half (n = 35), or one-fifth (n = 55)—for 10 consecutive days. Median 24-h urinary output of sulforaphane metabolites was 24.6, 10.3, and 4.3 µmol across the three doses, respectively. The high-dose group showed a statistically significant 63.2% increase in urinary benzene mercapturic acids compared with controls over the 10-day period. Changes in the one-half dose (+11.3%) and one-fifth dose (-6.4%) groups were not significantly different from placebo.
Chen JG, Johnson J, Egner P, et al. Am J Clin Nutr, 2019. PMID 31268126
2006 / Double-blind, placebo-controlled randomized phase I trial
Healthy volunteers in three cohorts received oral broccoli sprout extracts containing glucosinolates (25 or 100 micromol) or isothiocyanates (25 micromol) or placebo every 8 hours for 7 days following a crucifer-free diet. Mean cumulative excretion of dithiocarbamates as a fraction of dose was 17.8 +/- 8.6% for 25 micromol glucosinolate, 19.6 +/- 11.7% for 100 micromol glucosinolate, and 70.6 +/- 2.0% for 25 micromol isothiocyanate. Evaluation of 32 hematology and chemistry tests, including liver transaminases and thyroid function markers, revealed no significant or consistent subjective or objective toxicities associated with sprout extract ingestion.
Shapiro TA, Fahey JW, Dinkova-Kostova AT, et al. Nutr Cancer, 2006. PMID 16965241